Serum and skin levels of miR-369-3p in patients with psoriasis and their correlation with disease severity

European Journal of Dermatology

Volumn 23, Issue 5, 2013, Pages 608-613

  Guo, Sen ^a   Zhang, Weigang ^a   Weia, Chao ^a   Wang, Lei ^a   Zhu, Guannan ^a   Shi, Qiong ^a   Li, Shuli ^a   Ge, Rui ^a   Li, Kai ^a   Gao, Lin ^a   Gao, Tianwen ^a   Wang, Gang ^a   Li, Chunying ^a  

^a FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

microRNAs; miR 369 3p; Psoriasis; Psoriasis Area Severity Index; Tumor necrosis factor

Indexed keywords

ADAM10 ENDOPEPTIDASE; LIM KINASE 1; MICRORNA; MICRORNA 369 3P; SIRTUIN 1; TRANSCRIPTION FACTOR HES 1; TRANSCRIPTION FACTOR SP3; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; WNT5A PROTEIN;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IN VITRO STUDY; MALE; PATHOGENESIS; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; PSORIASIS SEVERITY INDEX; PSORIASIS VULGARIS; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; TISSUE LEVEL; YOUNG ADULT;

MICRORNAS; MIR-369-3P; PSORIASIS; PSORIASIS AREA SEVERITY INDEX; TUMOR NECROSIS FACTOR-Α;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CELLS, CULTURED; FEMALE; HUMANS; KERATINOCYTES; MALE; MICRORNAS; PSORIASIS; SEVERITY OF ILLNESS INDEX; SKIN; TUMOR NECROSIS FACTOR-ALPHA; YOUNG ADULT;

EID: 84889076151     PISSN: 11671122     EISSN: 19524013     Source Type: Journal    
DOI: 10.1684/ejd.2013.2148     Document Type: Article

References (23)

1. Nestle FO, Kaplan DH, Barker J. Psoriasis. N Engl J Med 2009; 361: 496-509.
2. Ambros V. The functions of animal microRNAs. Nature 2004; 431: 350-5.
3. Luo X, Zhang L, Li M, et al. The role of mir-125b in T lymphocytes in the pathogenesis of systemic lupus erythematosus. Clin Exp Rheumatol 2013; 31: 263-71.
4. Nohata N, Hanazawa T, Kinoshita T, et al. Tumour-seppressive microRNA-874 contributes to cell proliferation through targeting of histone deacetylase 1 in head and neck squamous cell carcinoma. Br J Cancer 2013; 108: 1648-58.
5. Profumo V, Gandellini P. MicroRNAs: Cobblestones on the Road to Cancer Metastasis. Crit Rev Oncog 2013; 18(4): 341-55.
6. Allegra A, Alonci A, Campo S, et al. Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer (review). Int J Oncol 2012; 41: 1897-912.
7. Xu N, Meisgen F, Butler LM, et al. MicroRNA-31 is overexpressed in psoriasis and modulates inflammatory cytokine and chemokine production in keratinocytes via targeting serine/threonine kinase 40. J Immunol 2013; 190: 678-88.
8. Xia J, Joyce CE, Bowcock AM, et al. Noncanonical microRNAs and endogenous siRNAs in normal and psoriatic human skin. Hum Mol Genet 2013; 22: 737-48.
9. Sonkoly E, Wei T, Janson PC, et al. MicroRNAs: novel regulators involved in the pathogenesis of psoriasis? PLoS One 2007; 2: e610.
10. Ichihara A, Jinnin M, Oyama R, et al. Increased serum levels of miR-1266 in patients with psoriasis vulgaris. Eur J Dermatol 2012; 22: 68-71.
11. Joyce C, Zhou X, Xia J, et al. Deep sequencing of small RNAs from human skin reveals major alterations in the psoriasis miRNAome. Hum Mol Genet 2011; 20: 4025-40.
12. Nickoloff BJ. The cytokine network in psoriasis. Arch Dermatol 1991; 127: 871-84.
13. Honma M, Benitah SA, Watt FM, et al. Role of LIM kinases in normal and psoriatic human epidermis. Mol Biol Cell 2006; 17: 1888-96.
14. Sestito R, Madonna S, Scarponi C, et al. STAT3-dependent effects of IL-22 in human keratinocytes are counterregulated by sirtuin 1 through a direct inhibition of STAT3 acetylation. FASEB J 2011; 25: 916-27.
15. Oh ST, Schramme A, Stark A, et al. Overexpression of ADAM 10 and ADAM 12 in lesional psoriatic skin. Br J Dermatol 2008; 158: 1371-3.
16. Zhang K, Hou R, Niu X, et al. Decreased colony formation of high proliferative potential colony-forming cells and granulocytemacrophagecolony-forming units and increased Hes-1 expression in bone marrow mononuclear cell from patients with psoriasis. Br J Dermatol 2010; 163: 93-101.
17. Lu X, Du J, Liang J, et al. Transcriptional regulatory network for psoriasis. J Dermatol 2013; 40(1): 48-53.
18. Reischl J, Schwenke S, Beekman JM, et al. Increased expression of Wnt5a in psoriatic plaques. J Invest Dermatol 2007; 127: 163-9.
19. Caldarola G, De Simone C, Carbone A, et al. TNFalpha and its receptors in psoriatic skin, before and after treatment with etanercept. Int J Immunopath Ph 2009; 22: 961.
20. Kristensen M, Chu C, Eedy D, et al. Localization of tumour necrosis factor-alpha (TNF-α) and its receptors in normal and psoriatic skin: epidermal cells express the 55-kD but not the 75-kD TNF receptor. Clin Exp Immunol 1993; 94: 354-62.
21. Kerkhof PC. The Psoriasis Area and Severity Index and alternative approaches for the assessment of severity: persisting areas of confusion. Br J Dermatol 1997; 137: 661-2.
22. Kroh EM, Parkin RK, Mitchell PS, et al. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods 2010; 50: 298-301.
23. Hunter MP, Ismail N, Zhang X, et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS One 2008; 3: e3694.